Novartis Ag (NVS) Income from Discontinued Operations (2013 - 2023)

Novartis Ag has disclosed Income from Discontinued Operations across 7 years of filings, most recently posting $5.8 billion for Q4 2023.

• In Q4 2023, Income from Discontinued Operations rose 673.77% year-over-year to $5.8 billion; the TTM figure through Dec 2023 stood at $6.3 billion (up 260.83% YoY), while the FY2023 annual figure was $6.3 billion, up 593.38% from the prior year.
• Income from Discontinued Operations came in at $5.8 billion for Q4 2023 at Novartis Ag, up from $250.0 million in the prior quarter.
• In the past five years, Income from Discontinued Operations ranged from a high of $5.8 billion in Q4 2023 to a low of $46.0 million in Q2 2023.
• Average Income from Discontinued Operations over 3 years is $1.5 billion, with a median of $499.0 million recorded in 2019.
• Year-over-year, Income from Discontinued Operations soared 11627.5% in 2019 and grew 2.04% in 2023.
• Over 3 years, Income from Discontinued Operations stood at $741.0 million in 2019, then rose by 1.89% to $755.0 million in 2022, then surged by 673.77% to $5.8 billion in 2023.
• Per Business Quant data, the three most recent Income from Discontinued Operations figures were $5.8 billion in Q4 2023, $250.0 million in Q3 2023, and $46.0 million in Q2 2023.